key: cord-0729625-0x2xh96e authors: Bakaeen, Faisal G.; Gillinov, A. Marc; Roselli, Eric E.; Chikwe, Joanna; Moon, Marc R.; Adams, David H.; Coselli, Joseph S.; Dearani, Joseph A.; Svensson, Lars G. title: Cardiac Surgery and the COVID-19 Pandemic: What We Know, What We Don’t Know, and What We Need to Do date: 2020-05-06 journal: J Thorac Cardiovasc Surg DOI: 10.1016/j.jtcvs.2020.04.101 sha: 31509643bc6af1026fdfb272aa7abe4f29aa6f2b doc_id: 729625 cord_uid: 0x2xh96e nan As it unfolds, the COVID-19 pandemic is proving to be the seminal challenge of our 50 generation. The human and economic toll has been felt across the globe, with no 51 proven effective treatment or vaccine on the horizon. 1 To impede viral transmission, states, all non-emergency cardiac surgery was suspended early in the response to the 96 rising curve of the population infected with COVID-19. The role of ECMO in treating critically ill COVID-19 patients is evolving, but mortality is For surgeons who get infected, when can they safely return to work? Should we wait 180 until they test negative for the virus or is there a more robust parameter? Some have speculated that the reluctance to be at hospitals during the pandemic and 182 the resultant delay in care could create a pool of patients who will enter the hospital in 183 more critical condition. For example, will there be a resurgence of mechanical 184 myocardial infarction complications such as papillary muscle ruptures with acute mitral 185 regurgitation, post-infarction ventricular septal defects, and free-wall ruptures, or more 186 patients presenting late with acute aortic syndromes? Of course, a bigger concern is 187 that many of these patients will never get care at all and die at home from potentially 188 treatable cardiovascular conditions. This concern is borne out, at least partly, in recent testing, rigorous contact tracing, and antibody testing? How useful is the latter and will it 208 be a reliable indicator of immunity? What is the risk of reinfection? Once states begin to 209 reopen for business, will there be a second wave of the pandemic, and will the surge be 210 just as bad as or even worse than the initial one? How long will it be before an effective and enduring relationships for safe and effective patient care. The benefits of this 281 collaboration will become more apparent when the pandemic is over. As we rise to the challenge and face this crisis with hope and determination, one 283 ponders how cardiac surgery might change. One thing that will definitely change is how 284 we manage our resources, from simple face masks to more complex safety equipment. Good stewardship of not only material, but also human assets, will be a priority. Looking 286 forward, nothing will be taken for granted, and contingencies will be part of any strategic 287 planning. Leadership, resiliency, and innovation that are in the genetic blueprint of the 288 cardiac surgeon will enable us to prevail and ensure a secure and bright future for our 289 specialty and for the well-being of our patients. Review of emerging pharmacotherapy for the treatment of coronavirus disease 299 2019 Canadian Society of Cardiac Surgeons. Cardiac surgery in Canada during the 306 COVID-19 pandemic: a guidance statement from the Canadian Society of Cardiac Surgeons COVID-19: crisis management in congenital heart surgery Adult cardiac surgery during the COVID-19 pandemic: a 314 tiered patient triage guidance statement Act as a Unit: the Story of Cleveland Clinic Rebuilder of Hearts, Dies at 99. The 320 New York Times The variety of cardiovascular presentations of COVID-19. Circulation Inside a major New York City hospital system battling coronavirus Italian Society 329 for Cardiac Surgery Task Force on COVID-19 Pandemic. The COVID-19 330 outbreak and its impact on hospitals in Italy: the model of cardiac surgery Prognosis when 334 using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-335 19 patients in China: a retrospective case series. Crit Care Initial ELSO guidance document: ECMO for COVID-19 patients with severe 339 cardiopulmonary failure 15 477 Characteristics of Health Care Personnel with COVID-19 -344 United States The characteristics of household transmission of COVID-19 Household tansmission of SARS-351 Response of cardiac surgery units to the COVID-19 pandemic: an internationally-355 based quantitative survey and expert recommendations Mortality while waiting for aortic valve replacement Adverse events while awaiting myocardial revascularization: 362 a systematic review and meta-analysis Reduction in ST-segment elevation cardiac catheterization laboratory activations 366 in the United States during COVID-19 pandemic A high-volume thoracic surgery division into the storm of 370 the COVID-19 pandemic Clinical course 373 of coronavirus disease 2019 in 11 patients after thoracic surgery and challenges 374 in diagnosis Predictive mathematical models of the 376 COVID-19 pandemic: underlying principles and value of projections Clinical characteristics and 379 outcomes of patients undergoing surgeries during the incubation period of 380 COVID-19 infection